Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Family issues in a psychoeducation group for women with a BRCA mutation.

Speice J, McDaniel SH, Rowley PT, Loader S.

Clin Genet. 2002 Aug;62(2):121-7.

PMID:
12220449
2.

Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD.

Genet Test. 2007 Fall;11(3):249-55.

3.

How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.

Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK.

J Clin Oncol. 2007 Aug 20;25(24):3705-11.

PMID:
17704419
4.

Benefit finding in response to BRCA1/2 testing.

Low CA, Bower JE, Kwan L, Seldon J.

Ann Behav Med. 2008 Feb;35(1):61-9. doi: 10.1007/s12160-007-9004-9. Epub 2008 Feb 15.

PMID:
18347905
5.

Communication of BRCA results and family testing in 1,103 high-risk women.

Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2211-9. doi: 10.1158/1055-9965.EPI-10-0325. Epub 2010 Aug 10.

6.

Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.

Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N.

Fam Cancer. 2005;4(2):115-9.

PMID:
15951961
7.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
8.

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.

van Dijk S, Timmermans DR, Meijers-Heijboer H, Tibben A, van Asperen CJ, Otten W.

J Clin Oncol. 2006 Aug 1;24(22):3672-7.

PMID:
16877736
9.

Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M.

Eur J Hum Genet. 2012 Jan;20(1):4-10. doi: 10.1038/ejhg.2011.146. Epub 2011 Aug 3.

10.

Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.

11.

Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysis.

Keenan LA, Lesniak KT, Guarnaccia CA, Althaus B, Ethington G, Blum JL.

J Genet Couns. 2004 Apr;13(2):157-76.

PMID:
15604630
12.

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.

Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH.

Health Expect. 2008 Sep;11(3):220-31. doi: 10.1111/j.1369-7625.2008.00494.x.

13.

Theory development from studies with young women with breast cancer who are BRCA mutation negative.

Hamilton R, Kopin S.

ANS Adv Nurs Sci. 2013 Apr-Jun;36(2):E41-53. doi: 10.1097/ANS.0b013e3182901ff1.

PMID:
23644270
14.

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

JAMA. 2006 Mar 22;295(12):1379-88.

PMID:
16551709
15.
16.

A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations.

Esplen MJ, Hunter J, Leszcz M, Warner E, Narod S, Metcalfe K, Glendon G, Butler K, Liede A, Young MA, Kieffer S, DiProspero L, Irwin E, Wong J.

Cancer. 2004 Nov 15;101(10):2327-40.

17.

Reproductive decision-making in young female carriers of a BRCA mutation.

Donnelly LS, Watson M, Moynihan C, Bancroft E, Evans DG, Eeles R, Lavery S, Ormondroyd E.

Hum Reprod. 2013 Apr;28(4):1006-12. doi: 10.1093/humrep/des441. Epub 2013 Jan 4.

PMID:
23293217
18.
19.

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.

Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW.

Breast J. 2004 Nov-Dec;10(6):475-80.

PMID:
15569201
20.

Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress.

Landsbergen KM, Brunner HG, Manders P, Hoogerbrugge N, Prins JB.

Genet Couns. 2010;21(4):423-37.

PMID:
21290972

Supplemental Content

Support Center